Importer of Controlled Substances Application: Sigma Aldrich Co., LLC, 60903-60904 [2018-25867]

Download as PDF 60903 Federal Register / Vol. 83, No. 228 / Tuesday, November 27, 2018 / Notices Controlled substance Drug code Phencyclidine ............................................................................................................................................................. 4-Anilino-N-phenethyl-4-piperidine (ANPP) ............................................................................................................... Phenylacetone ............................................................................................................................................................ 1-Piperidinocyclohexanecarbonitrile ........................................................................................................................... Cocaine ...................................................................................................................................................................... Codeine ...................................................................................................................................................................... Etorphine HCl ............................................................................................................................................................. Dihydrocodeine .......................................................................................................................................................... Oxycodone ................................................................................................................................................................. Hydromorphone .......................................................................................................................................................... Ecgonine .................................................................................................................................................................... Ethylmorphine ............................................................................................................................................................ Hydrocodone .............................................................................................................................................................. Levomethorphan ........................................................................................................................................................ Levorphanol ................................................................................................................................................................ Isomethadone ............................................................................................................................................................. Meperidine .................................................................................................................................................................. Meperidine intermediate-B ......................................................................................................................................... Methadone ................................................................................................................................................................. Dextropropoxyphene, bulk (non-dosage forms) ........................................................................................................ Morphine .................................................................................................................................................................... Thebaine .................................................................................................................................................................... Oxymorphone ............................................................................................................................................................. Thiafentanil ................................................................................................................................................................. Alfentanil ..................................................................................................................................................................... Remifentanil ............................................................................................................................................................... Sufentanil ................................................................................................................................................................... Carfentanil .................................................................................................................................................................. Tapentadol ................................................................................................................................................................. Fentanyl ...................................................................................................................................................................... The company plans to bulk manufacture the listed controlled substances to produce forensic and research analytical reference standards for distribution to its customers. issuance of the proposed registration on or before December 27, 2018. Such persons may also file a written request for a hearing on the application on or before December 27, 2018. Dated: November 16, 2018. John J. Martin, Assistant Administrator. ADDRESSES: [FR Doc. 2018–25865 Filed 11–26–18; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE [Docket No. DEA–392] Drug Enforcement Administration Importer of Controlled Substances Application: Sigma Aldrich Co., LLC ACTION: Notice of application. Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the DATES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for hearing must be sent to: Drug Enforcement Administration, Attn: Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for hearing should also be sent to: (1) Drug Enforcement Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, Springfield, Virginia 22152; and (2) Drug Enforcement Administration, Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. The Attorney General has delegated his SUPPLEMENTARY INFORMATION: amozie on DSK3GDR082PROD with NOTICES1 Jkt 247001 PO 00000 Frm 00083 Fmt 4703 II II II II II II II II II II II II II II II II II II II II II II II II II II II II II II Drug code Cathinone ................................................................................................................................................................ Methcathinone ......................................................................................................................................................... Mephedrone (4-Methyl-N-methylcathinone) ............................................................................................................ Aminorex ................................................................................................................................................................. Gamma Hydroxybutyric Acid ................................................................................................................................... Methaqualone .......................................................................................................................................................... Alpha-ethyltryptamine .............................................................................................................................................. Ibogaine ................................................................................................................................................................... Lysergic acid diethylamide ...................................................................................................................................... 17:45 Nov 26, 2018 7471 8333 8501 8603 9041 9050 9059 9120 9143 9150 9180 9190 9193 9210 9220 9226 9230 9233 9250 9273 9300 9333 9652 9729 9737 9739 9740 9743 9780 9801 authority under the Controlled Substances Act to the Administrator of the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority to exercise all necessary functions with respect to the promulgation and implementation of 21 CFR part 1301, incident to the registration of manufacturers, distributors, dispensers, importers, and exporters of controlled substances (other than final orders in connection with suspension, denial, or revocation of registration) has been redelegated to the Assistant Administrator of the DEA Diversion Control Division (‘‘Assistant Administrator’’) pursuant to section 7 of 28 CFR part 0, appendix to subpart R. In accordance with 21 CFR 1301.34(a), this is notice that on February 21, 2018, Sigma Aldrich Co., LLC, 3500 Dekalb Street, Saint Louis, Missouri 63118 applied to be registered as an importer of the following basic classes of controlled substances: Controlled substance VerDate Sep<11>2014 Schedule Sfmt 4703 E:\FR\FM\27NON1.SGM 27NON1 1235 1237 1248 1585 2010 2565 7249 7260 7315 Schedule I I I I I I I I I 60904 Federal Register / Vol. 83, No. 228 / Tuesday, November 27, 2018 / Notices Controlled substance Drug code Marihuana ................................................................................................................................................................ Tetrahydrocannabinols ............................................................................................................................................ Mescaline ................................................................................................................................................................ 4-Bromo-2,5-dimethoxyamphetamine ..................................................................................................................... 4-Bromo-2,5-dimethoxyphenethylamine .................................................................................................................. 4-Methyl-2,5-dimethoxyamphetamine ..................................................................................................................... 2,5-Dimethoxyamphetamine .................................................................................................................................... 3,4-Methylenedioxyamphetamine ............................................................................................................................ N-Hydroxy-3,4-methylenedioxyamphetamine .......................................................................................................... 3,4-Methylenedioxy-N-ethylamphetamine ............................................................................................................... 3,4-Methylenedioxymethamphetamine .................................................................................................................... 4-Methoxyamphetamine .......................................................................................................................................... Bufotenine ............................................................................................................................................................... Diethyltryptamine ..................................................................................................................................................... Dimethyltryptamine .................................................................................................................................................. Psilocyn ................................................................................................................................................................... 1-[1-(2-Thienyl)cyclohexyl]piperidine ....................................................................................................................... N-Benzylpiperazine ................................................................................................................................................. MDPV (3,4-Methylenedioxypyrovalerone) ............................................................................................................... Heroin ...................................................................................................................................................................... Normorphine ............................................................................................................................................................ Etonitazene .............................................................................................................................................................. Amobarbital ............................................................................................................................................................. Secobarbital ............................................................................................................................................................. Glutethimide ............................................................................................................................................................ Nabilone .................................................................................................................................................................. Phencyclidine .......................................................................................................................................................... Diphenoxylate .......................................................................................................................................................... Ecgonine .................................................................................................................................................................. Ethylmorphine .......................................................................................................................................................... Levorphanol ............................................................................................................................................................. Meperidine ............................................................................................................................................................... Thebaine .................................................................................................................................................................. Opium, powdered .................................................................................................................................................... Levo-alphacetylmethadol ......................................................................................................................................... The company plans to import the listed controlled substances for sale to research facilities for drug testing and analysis. In reference to drug codes 7360 and 7370, the company plans to import a synthetic cannabidiol and a synthetic tetrahydrocannabinol. No other activities for these drug codes are authorized for this registration. Dated: November 16, 2018. John J. Martin, Assistant Administrator. [FR Doc. 2018–25867 Filed 11–26–18; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE amozie on DSK3GDR082PROD with NOTICES1 [OMB Number 1121–NEW] Agency Information Collection Activities; Proposed eCollection eComments Requested; Approval of a New Collection; Comments Requested: National Survey of Victim Service Providers (NSVSP) Bureau of Justice Statistics, Department of Justice. ACTION: 30-Day Notice. AGENCY: The Department of Justice (DOJ), Office of Justice Programs, SUMMARY: VerDate Sep<11>2014 17:45 Nov 26, 2018 Jkt 247001 Bureau of Justice Statistics, will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. This proposed information collection was previously published in the Federal Register at Volume 83, Number 136, page 32908, July 16, 2018, allowing for a 60 day comment period. DATES: Comments are encouraged and will be accepted for 30 days until December 27, 2018. FOR FURTHER INFORMATION CONTACT: If you have additional comments especially on the estimated public burden or associated response time, suggestions, or need a copy of the proposed information collection instrument with instructions or additional information, please contact Barbara Oudekerk, Statistician, Bureau of Justice Statistics, 810 Seventh Street NW, Washington, DC 20531 (email: Barbara.a.oudekerk@usdoj.gov; telephone: 202–616–3904). SUPPLEMENTARY INFORMATION: Written comments and suggestions from the public and affected agencies concerning the proposed collection of information are encouraged. Your comments should PO 00000 Frm 00084 Fmt 4703 Sfmt 4703 7360 7370 7381 7391 7392 7395 7396 7400 7402 7404 7405 7411 7433 7434 7435 7438 7470 7493 7535 9200 9313 9624 2125 2315 2550 7379 7471 9170 9180 9190 9220 9230 9333 9639 9648 Schedule I I I I I I I I I I I I I I I I I I I I I I II II II II II II II II II II II II II address one or more of the following four points: —Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the Bureau of Justice Statistics, including whether the information will have practical utility; —Evaluate the accuracy of the agency’s estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; —Evaluate whether and if so how the quality, utility, and clarity of the information to be collected can be enhanced; and —Minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submission of responses. Overview of This Information Collection (1) Type of Information Collection: New collection. E:\FR\FM\27NON1.SGM 27NON1

Agencies

[Federal Register Volume 83, Number 228 (Tuesday, November 27, 2018)]
[Notices]
[Pages 60903-60904]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-25867]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

[Docket No. DEA-392]

Drug Enforcement Administration


Importer of Controlled Substances Application: Sigma Aldrich Co., 
LLC

ACTION: Notice of application.

-----------------------------------------------------------------------

DATES: Registered bulk manufacturers of the affected basic classes, and 
applicants therefore, may file written comments on or objections to the 
issuance of the proposed registration on or before December 27, 2018. 
Such persons may also file a written request for a hearing on the 
application on or before December 27, 2018.

ADDRESSES: Written comments should be sent to: Drug Enforcement 
Administration, Attention: DEA Federal Register Representative/DPW, 
8701 Morrissette Drive, Springfield, Virginia 22152. All requests for 
hearing must be sent to: Drug Enforcement Administration, Attn: 
Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All 
requests for hearing should also be sent to: (1) Drug Enforcement 
Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, 
Springfield, Virginia 22152; and (2) Drug Enforcement Administration, 
Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, 
Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION: The Attorney General has delegated his 
authority under the Controlled Substances Act to the Administrator of 
the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority 
to exercise all necessary functions with respect to the promulgation 
and implementation of 21 CFR part 1301, incident to the registration of 
manufacturers, distributors, dispensers, importers, and exporters of 
controlled substances (other than final orders in connection with 
suspension, denial, or revocation of registration) has been redelegated 
to the Assistant Administrator of the DEA Diversion Control Division 
(``Assistant Administrator'') pursuant to section 7 of 28 CFR part 0, 
appendix to subpart R.
    In accordance with 21 CFR 1301.34(a), this is notice that on 
February 21, 2018, Sigma Aldrich Co., LLC, 3500 Dekalb Street, Saint 
Louis, Missouri 63118 applied to be registered as an importer of the 
following basic classes of controlled substances:

------------------------------------------------------------------------
      Controlled substance           Drug code           Schedule
------------------------------------------------------------------------
Cathinone.......................            1235  I
Methcathinone...................            1237  I
Mephedrone (4-Methyl-N-                     1248  I
 methylcathinone).
Aminorex........................            1585  I
Gamma Hydroxybutyric Acid.......            2010  I
Methaqualone....................            2565  I
Alpha-ethyltryptamine...........            7249  I
Ibogaine........................            7260  I
Lysergic acid diethylamide......            7315  I

[[Page 60904]]

 
Marihuana.......................            7360  I
Tetrahydrocannabinols...........            7370  I
Mescaline.......................            7381  I
4-Bromo-2,5-dimethoxyamphetamine            7391  I
4-Bromo-2,5-                                7392  I
 dimethoxyphenethylamine.
4-Methyl-2,5-                               7395  I
 dimethoxyamphetamine.
2,5-Dimethoxyamphetamine........            7396  I
3,4-Methylenedioxyamphetamine...            7400  I
N-Hydroxy-3,4-                              7402  I
 methylenedioxyamphetamine.
3,4-Methylenedioxy-N-                       7404  I
 ethylamphetamine.
3,4-                                        7405  I
 Methylenedioxymethamphetamine.
4-Methoxyamphetamine............            7411  I
Bufotenine......................            7433  I
Diethyltryptamine...............            7434  I
Dimethyltryptamine..............            7435  I
Psilocyn........................            7438  I
1-[1-(2-                                    7470  I
 Thienyl)cyclohexyl]piperidine.
N-Benzylpiperazine..............            7493  I
MDPV (3,4-                                  7535  I
 Methylenedioxypyrovalerone).
Heroin..........................            9200  I
Normorphine.....................            9313  I
Etonitazene.....................            9624  I
Amobarbital.....................            2125  II
Secobarbital....................            2315  II
Glutethimide....................            2550  II
Nabilone........................            7379  II
Phencyclidine...................            7471  II
Diphenoxylate...................            9170  II
Ecgonine........................            9180  II
Ethylmorphine...................            9190  II
Levorphanol.....................            9220  II
Meperidine......................            9230  II
Thebaine........................            9333  II
Opium, powdered.................            9639  II
Levo-alphacetylmethadol.........            9648  II
------------------------------------------------------------------------

    The company plans to import the listed controlled substances for 
sale to research facilities for drug testing and analysis. In reference 
to drug codes 7360 and 7370, the company plans to import a synthetic 
cannabidiol and a synthetic tetrahydrocannabinol. No other activities 
for these drug codes are authorized for this registration.

    Dated: November 16, 2018.
John J. Martin,
Assistant Administrator.
[FR Doc. 2018-25867 Filed 11-26-18; 8:45 am]
 BILLING CODE 4410-09-P